Partnership targets Alzheimer’s and Parkinson’s with novel delivery platforms and precision medicine approaches.
Partnership targets Alzheimer’s and Parkinson’s with novel delivery platforms and precision medicine approaches.
Next-generation gene editing powers new hope for hard-to-treat solid tumors in early human trials.
A landmark Australian trial will test olfactory cell transplantation combined with intensive rehab to restore function in chronic …
Personalized mRNA cancer vaccine combined with Keytruda delivers sustained recurrence-free survival in high-risk melanoma patients, reinforcing immunotherapy’s future.
Already a subscriber? Log in